Galanthamine possesses anti-acetylcholinesterase activity, used for the treatment of Alzheimer’s disease, and is approved for use in the European Union and the United States [16]; lycorine possesses cytotoxicity and antitumor properties [17]; montanine possesses anxiolytic, antidepressant and anticonvulsive activities as well as immunomodulatory properties [18]; pancratistatin and narciclasine possess antitumor activity [19,20]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.